REGISTERED
on 13 Oct 2020
Last Applicant/ Owned by
4-2855 Argentia Road
MISSISSAUGA, ONTARIO
CA
L5N8G6
Serial Number
86039785 filed on 16th Aug 2013
Registration Number
6172150 registered on 13th Oct 2020
Correspondent Address
Christopher J. Schulte
Filing Basis
1. intent to use
Disclaimer
NO DATA
PLASMACAP
Protein chromatography equipment for capturing biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate Construction of biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services in t Read More
Classification Information
Class [001]
Chemical Products
Resins, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate ion exchange, mixed mode, and affinity resins
Class [005]
Pharmaceutical Products
Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins
Class [009]
Computer & Software Products & Electrical & Scientific Products
Protein chromatography equipment for capturing biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate
Class [037]
Construction and Repair Services
Construction of biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services in the field of construction of biopharmaceutical and plasma manufacturing services
Class [040]
Treatment & Processing of Materials Services
Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics
Class [041]
Education and Entertainment Services
Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment
Class [042]
Computer & Software Services & Scientific Services
Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design of chromatography equipment, and design of biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering
Mark Details
Serial Number
No 86039785
Mark Type
No Service Mark
Attorney Docket Number
No 7933.379US01
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th Sep 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 08th Sep 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 08th Sep 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 08th Sep 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 08th Sep 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 06th Jul 2021 | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED |
| 01st Jul 2021 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| 13th Oct 2020 | REGISTERED-PRINCIPAL REGISTER |
| 28th Jul 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 28th Jul 2020 | PUBLISHED FOR OPPOSITION |